Adverum Biotechnologies, Inc. Share Price
Equities
ADVM
US00773U2078
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.19 USD | -2.13% | -18.96% | +22.08% |
03-21 | Adverum Biotechnologies Files $200 Million Mixed Shelf | MT |
03-19 | RBC Cuts Price Target on Adverum Biotechnologies to $2 From $3, Keeps Sector Perform, Speculative Risk | MT |
Sales 2024 * | - | Sales 2025 * | 10M 799M | Capitalization | 191M 15.24B |
---|---|---|---|---|---|
Net income 2024 * | -111M -8.87B | Net income 2025 * | -143M -11.43B | EV / Sales 2024 * | - |
Net cash position 2024 * | 149M 11.89B | Net cash position 2025 * | 136M 10.83B | EV / Sales 2025 * | 5.52 x |
P/E ratio 2024 * |
-1.7
x | P/E ratio 2025 * |
-1.61
x | Employees | 121 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.94% |
Latest transcript on Adverum Biotechnologies, Inc.
1 day | -2.13% | ||
1 week | -18.96% | ||
Current month | -35.01% | ||
1 month | -35.01% | ||
3 months | -2.18% | ||
6 months | -3.25% | ||
Current year | +22.08% |
Managers | Title | Age | Since |
---|---|---|---|
Laurent Fischer
CEO | Chief Executive Officer | 60 | 14/06/20 |
Linda Rubinstein
DFI | Director of Finance/CFO | 58 | 11/12/22 |
Bill Tan
CTO | Chief Tech/Sci/R&D Officer | - | 28/02/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 15/04/20 | |
Clarence Machado
CHM | Chairman | 60 | 13/03/17 |
Laurent Fischer
CEO | Chief Executive Officer | 60 | 14/06/20 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 9.19 | -2.13% | 798,696 |
25/04/24 | 9.39 | -7.85% | 847,544 |
24/04/24 | 10.19 | -7.36% | 404,696 |
23/04/24 | 11 | -3.00% | 305,071 |
22/04/24 | 11.34 | 0.00% | 168,238 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.08% | 191M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- ADVM Stock